ADIPOQ and Hepatic steatosis: Treatment with adiponectin-expressing thymocytes leads to an increase of Treg and a decrease of Th17 cells in the liver, which at least partly contribute to the prevention of HFD-induced hepatic steatosis and injury in WT mice.